Trial intelligence / Profile preview

Anthocyanin Mouthrinse for Orthodontic Oral Inflammation

NCT02536781Phase 3Completed

Sponsor
Khon Kaen University
Start
Aug 2015
Primary completion
Jan 2016
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Oral inflammation (2 arms), sponsored by Khon Kaen University. Primary endpoint: Wound Size Reduction at Day 7. Started Aug 2015; status: completed.

02

Conditions

Oral inflammation

Beyond the preview

Go deeper on NCT02536781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02536781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call